EU-Funded Project

IDEAL ageing square IDEAL ageing

Abbreviation:

IDEAL ageing

Title:

Integrated research on DEvelopmental determinants of Aging and Longevity.

In short:

Study of the role of epigenetics in ageing and longevity.

Tags:

Human R&D

RD IDEAL ageing

Project Details

Funding scheme:

FP7-HEALTH-2010 – Grant Agreement ID 259679

Time frame:

1 February 2011 to 31 January 2016

Description:

Changes in how DNA is translated by means other than modifications in the basic code are referred to as f epigenetics. The EU-funded IDEAL ageing project has examined the role of epigenetics in growing old, even before birth in the womb. The research also looked into the genetic control of the ageing process. GenomeScan offered its expertise in high-throughput and state-of-the-art molecular testing, providing an insight into the epigenetic mechanisms that underpin the variation in gene expression across life phases and environments for developmental and adult phenotypic plasticity.

Output:

Product (service): The methylation array service (EPIC-array) is now available for all GenomeScan customers.

Acknowledgements:

EU IDEAL ageingThis project has received funding from the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant agreement No 259679.